• Blocked ducts and mastitis: Management in breastfeeding women
    Nov 16 2026

    In this episode of The Good GP, host Dr Karin Sekhon is joined by Dr Kate Moriarty, a GP and lactation consultant, to discuss the modern approach to blocked ducts and mastitis in breastfeeding women.

    Focusing on the distinction between blocked ducts and mastitis, now recognised as points on a spectrum of breast tissue inflammation rather than simple ductal obstruction. One concept discussed was the updated understanding of breast physiology, with alveolar overdistension and inflammation being key contributors rather than milk stasis.

    They also identified the risk factors, particularly oversupply (hyperlactation), extended periods between feeds, and potential alterations in the breast microbiome. Exploring how unnecessary pumping and feeding practices can reinforce oversupply and contribute to inflammation.

    They also talked about management, including the move away from heat and deep massage (which may worsen inflammation) towards a hands-off approach using ice, analgesia, and supportive care. Antibiotics should be reserved for suspected bacterial mastitis when there are persistent or worsening symptoms.

    Providing advice on breastfeeding during mastitis, the maintenance of typical feeding routines and avoiding excess pumping. Preventative strategies focused on supporting physiological milk transfer, cautious use of pumps, and being alert to signs of oversupply, with limited evidence for measures such as probiotics and sunflower lecithin.

    They concluded with the new clinical perspective: treating mastitis as an inflammatory process, supporting breastfeeding physiology, and reserving antibiotics for clear infection.

    Links & Resources:

    • For patients and clinicians: Engorgement | Australian Breastfeeding Association https://www.breastfeeding.asn.au/resources/engorgement
    • For clinicians:
    • Academy of Breastfeeding Medicine protocols: https://www.bfmed.org/protocols
    • Mastitis - BFM-2022-29207-kbm-ver9-Mitchell_2P 360..376 https://www.bfmed.org/assets/ABM%20Protocol%20%2336.pdf The strains of probiotics discussed that have some evidence in preventing mastitis are limosilactobacillus fermentum and ligilactobacillus salivarus
    • Pain - ABM Clinical Protocol #26: Persistent Pain with Breastfeeding https://www.bfmed.org/assets/DOCUMENTS/PROTOCOLS/26-persistent-pain-protocol-english.pdf

    The Good GP Podcast is a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at www.talkinghealthtech.com/podcast/network

    If you have any questions or would like to contact The Good GP, send an email to thegoodgp@gmail.com. Visit www.thegoodgp.com.au for previous episodes and more information. You can also find us on our Instagram page: @thegoodgppodcast. Follow us for more updates!

    Show More Show Less
    24 mins
  • New Advances in Breast Density Reporting and What It Means for Patients and GPs
    Nov 9 2026

    In this episode of This Could Save Your Life podcast, Dr Catherine Bourke is joined by Dr Tessa McLean for an in-depth discussion on the clinical relevance of breast density and its reporting in breast cancer screening. Focusing on the recent rollout of breast density reporting through BreastScreen programs across several Australian states, and what this means for patients and general practitioners.

    They talked about the clinical relevance of breast density for both cancer risk and the diagnostic performance of mammography. The masking effect of dense breast tissue can lower mammography sensitivity, making early cancer detection more challenging.

    They explored how GPs can support patients who receive a dense breast notification, recommending the use of validated breast cancer risk assessment tools like iPrevent for individualised risk evaluation. While breast density is one factor, several points were raised about the importance of considering other risk factors including family history, genetic susceptibility, and lifestyle.

    Recommendations were provided for follow-up: women should consult their GP for assessment and discussion of additional screening if needed, guided by new Department of Health resources.

    Concluding with strategies for risk reduction, including exercise, maintaining a healthy weight, reducing alcohol intake, not smoking, and breastfeeding where possible.

    Link & Resources:

    • Listen to our Episode: Breast cancer Awareness: Screening, prevention and risk factors: https://thegoodgp.com.au/episode/breast-cancer-awareness-screening-prevention-and-risk-factors/
    • iPrevent Breast Cancer Risk Assessment Tool: https://www.breastcancertrials.org.au/breast-cancer-resources/iprevent/?utm_source=google&utm_medium=cpc&utm_campaign=comms-iprevent-leads-au&gad_source=1&gad_campaignid=23677845721&gbraid=0AAAAAqA0HjKMpgHSG_Y2EblNd_8Hrpfh_&gclid=Cj0KCQiA77DXBhCHARIsAHf2MNpl89YxFElLltP_yqM3AYRa3k63iYJ1n9rPcqX4SpFATpnD-qQlO40aAtLAEALw_wcB
    • Breast density GP guidance tool: https://www.health.gov.au/our-work/breastscreen-australia-program/health-professionals/breast-density-information-for-gps?language=en

    This Could Save Your Life Podcast is under The Good GP podcast, a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at www.talkinghealthtech.com/podcast/network

    If you have any questions or would like to contact The Good GP, send an email to thegoodgp@gmail.com. Visit www.thegoodgp.com.au for previous episodes and more information. You can also find us on our Instagram page: @thegoodgppodcast. Follow us for more updates!

    Show More Show Less
    16 mins
  • Updated approach to atrial fibrillation for GPs
    Nov 2 2026

    In this episode of The Good GP, host Dr Ash Bowden is joined by Professor Rukshen Weerasooriya, Clinical Professor of Medicine at UWA and cardiac electrophysiologist, to discuss the updated management of atrial fibrillation (AF) and what this means for general practitioners.

    Professor Rukshen explains the recent introduction of pulsed field ablation, a non-thermal technique that has made AF ablation procedures faster and safer by reducing complications such as esophageal and nerve injury. This development has expanded the availability of ablation and changed practice guidelines, now recommending ablation earlier in a patient’s AF journey rather than as a last resort.

    Key risk factors and modifiable contributors to AF outcomes are discussed, including limiting alcohol, achieving weight loss (especially a 10% reduction for overweight patients), managing blood pressure, and treating sleep apnea.

    Also covering expected success rates, stressing that ablation is highly effective (up to 90% suppression in ideal patients) but not curative, and early referral to a cardiac electrophysiologist, ideally within the first year of diagnosis, maximises patient benefit. Highlighting the key investigations to organise before referral: ECG, echocardiogram (especially for left atrial size and ventricular function), and Holter monitoring.

    The broader significance of AF is addressed, with its rising prevalence, elevated stroke and heart failure risk, and the psychological burden on patients underscored as reasons to prioritise detection and early, proactive management.

    Links & Resources:

    • 2024 Cardiac Society of Australia and New Zealand Expert Position Statement
    • HEAD 2 TOES Management

    The Good GP Podcast is a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at www.talkinghealthtech.com/podcast/network

    If you have any questions or would like to contact The Good GP, send an email to thegoodgp@gmail.com. Visit www.thegoodgp.com.au for previous episodes and more information. You can also find us on our Instagram page: @thegoodgppodcast. Follow us for more updates!

    Show More Show Less
    15 mins
  • Bradycardia diagnosis and general management
    Oct 26 2026

    In this episode of The Good GP, host Dr Kristiana Pederick welcomes Dr Justin Ng, a specialist cardiologist and electrophysiologist specialising in the diagnosis and management of arrhythmias. They discuss common presentations of bradycardia and how to distinguish between physiological and pathological low heart rates.

    Dr Justin highlights red flags in the presentation, investigation, and general management of bradyarrhythmia, as well as the uses and limitations of wearable tracking devices, such as smartwatches.

    They explore typical presentations of bradycardia, including syncope, near-syncope, reduced exercise tolerance, and cognitive decline in older adults. Dr Justin emphasises the importance of clinical context when distinguishing between physiological and pathological bradycardia, taking into account the patient's age, fitness level, symptoms, and the circumstances in which a low heart rate is identified.

    They also discuss management principles, including reserving pacemaker implantation for symptomatic or irreversible cases. The importance of taking a thorough patient history and correlating symptoms with documented bradycardia is emphasised to help determine the urgency of management and guide further investigations.

    The Good GP Podcast is a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at www.talkinghealthtech.com/podcast/network

    If you have any questions or would like to contact The Good GP, send an email to thegoodgp@gmail.com. Visit www.thegoodgp.com.au for previous episodes and more information. You can also find us on our Instagram page: @thegoodgppodcast. Follow us for more updates!

    Show More Show Less
    26 mins
  • Alzheimer's Disease biomarker testing
    Oct 19 2026

    In this episode of The Good GP, Dr Krystyna de Lange speaks with Dr Steph Daly, GP with a special interest in aged care and dementia, about the introduction of plasma biomarkers, specifically the p-Tau 217 blood test for Alzheimer’s disease. They explore what the p-Tau 217 test measures, its reliability, and its role in primary care.

    Dr Steph Daly outlines that the test shows high positive and negative predictive value for Alzheimer’s pathology when used in the appropriate, symptomatic patient group, typically those over 55 presenting with clear cognitive or memory symptoms. Discussing the practical process for GPs to request the test, expected costs, and considerations for both urban and rural settings.

    They emphasise the need for pre-test counselling, careful patient selection, and the importance of structured clinical assessment to ensure meaningful use of the test. The application of this biomarker in asymptomatic individuals is not recommended at present, due to limited clinical utility and potential psychological harm.

    Listeners are encouraged to approach the test thoughtfully, seek additional education, and use it initially in patients where clinical suspicion of Alzheimer’s disease is already high.

    Links & Resources:

    • Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment study: https://jamanetwork.com/journals/jama/article-abstract/2851720
    • The Nun Study: Insights from 30 years of aging and dementia research: https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.14626
    • Link to webinar and information on biomarker study currently being carried out in Australia: https://www.australiandementianetwork.org.au/improved-extended-study-blood-based-biomarkers-for-alzheimers-disease-in-primary-care-project/

    The Good GP Podcast is a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at www.talkinghealthtech.com/podcast/network

    If you have any questions or would like to contact The Good GP, send an email to thegoodgp@gmail.com. Visit www.thegoodgp.com.au for previous episodes and more information. You can also find us on our Instagram page: @thegoodgppodcast. Follow us for more updates!

    Show More Show Less
    25 mins
  • Naltrexone in alcohol use disorder
    Oct 12 2026

    In this episode of The Good GP, host Dr Krystyna De Lange speaks with Dr David Leitinger, a GP with a special interest in addiction medicine, about the practical use of naltrexone for managing alcohol use disorder (AUD).

    Dr Leitinger explains how naltrexone, an opioid antagonist, disrupts the endorphin-mediated reward of alcohol consumption, helping patients gradually reduce intake and unlearn habitual drinking behaviours. He highlights that naltrexone can be prescribed while patients are still drinking, not only during abstinence, and discusses flexible prescribing methods including daily dosing and the “Sinclair Method” of targeted dosing prior to drinking.

    Important considerations covered include contraindications such as concurrent opioid use and the approach to temporary cessation if opioid analgesia is needed. Dr Leitinger reassures that naltrexone is generally safe in patients with liver disease and recommends baseline and follow-up LFTs, though testing should not be a barrier to therapy.

    A case study illustrates practical patient outcomes, expectations, and follow-up. Strategies for supporting patients through lapses and individualising success measures are discussed, as well as where naltrexone fits alongside other first-line options like acamprosate. The value of harm reduction and ongoing patient support in primary care is emphasised.

    Link & Resources:

    • AJGP article on naltrexone in alcohol use disorder: https://www1.racgp.org.au/ajgp/2026/january-february/naltrexone
    • Community Access to Pharmacotherapy for Alcohol (CAPA) EOI Form: https://forms.cloud.microsoft/Pages/ResponsePage.aspx?id=xMYIFZVfdU-KZ5mS34Mn6CJfQHBGKCREk2C2wuYgdyNUM0IzSDc4WTVXMkNGT1VXWkYxMlNGQ0FIVy4u&origin=QRCode
    • A 2-step reduction in WHO alcohol risk drinking levels (rather than abstinence) for harm reduction: https://pmc.ncbi.nlm.nih.gov/articles/PMC12739655/
    • Stronger evidence for the effectiveness of naltrexone: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2727384

    The Good GP Podcast is a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at www.talkinghealthtech.com/podcast/network

    If you have any questions or would like to contact The Good GP, send an email to thegoodgp@gmail.com. Visit www.thegoodgp.com.au for previous episodes and more information. You can also find us on our Instagram page: @thegoodgppodcast. Follow us for more updates!

    Show More Show Less
    21 mins
  • Antidepressant during pregnancy: Pharmacoepidemiologist’s perspective
    Oct 5 2026

    In this episode of The Good GP, Dr Julia Rawlinson speaks with Dr Florence Martin, an epidemiologist specialising in pregnancy pharmacoepidemiology. Dr Martin discusses her recent study examining the relationship between first trimester antidepressant use and miscarriage risk, using UK primary care data from the CPRD GOLD database.

    Dr Martin explains the definitions used for trimesters and miscarriage, and highlights the understanding confounding by indication; how underlying depression, rather than the use of antidepressants, may skew observed associations in raw data. After adjusting for confounding factors, her research found only a modest increase in miscarriage risk for women using antidepressants in the first trimester, with the absolute risk rising slightly from 13.1% to 13.6%.

    She further outlines the difference in risk between women who were already taking antidepressants when becoming pregnant and those who started during the first trimester. The findings suggest no increased miscarriage risk for continuing users, while those newly starting medication may show a slight increase, potentially due to residual confounding or early pregnancy detection bias.

    Dr Martin encourages GPs to communicate absolute risk clearly and to consider each patient’s context when discussing antidepressant use in pregnancy.

    Link & Resources:

    • https://bjgp.org/content/75/761/e843

    The Good GP Podcast is a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at www.talkinghealthtech.com/podcast/network

    If you have any questions or would like to contact The Good GP, send an email to thegoodgp@gmail.com. Visit www.thegoodgp.com.au for previous episodes and more information. You can also find us on our Instagram page: @thegoodgppodcast. Follow us for more updates!

    Show More Show Less
    19 mins
  • Antidepressant during pregnancy: Psychiatrist’s perspective
    Sep 28 2026

    In this episode of the Good GP, Dr Julia Rawlinson speaks with Dr Julia Feutrill, consultant psychiatrist at King Edward Memorial Hospital and co-director of the Elizabeth Clinic. They discuss the complexities of antidepressant use during pregnancy, providing GPs with practical advice for navigating these conversations.

    Covering key assessment considerations, such as the severity of illness, history of hormonal sensitivity, trauma, and family psychiatric history. Dr Feutrill stresses the need to treat symptoms to remission rather than opting for subtherapeutic dosing, highlighting the low absolute risk of congenital malformations from antidepressant medications, especially compared to other modifiable risk factors.

    Sertraline is identified as the antidepressant with the most robust safety data for pregnancy. Examining neonatal adaptation syndrome and outlines current understanding regarding dose adjustments during pregnancy. Guidance is provided on managing abrupt discontinuation and when GP referral to psychiatry is appropriate.

    Dr Feutrill also draws attention to the growing recognition of hormonal sensitivity’s impact on mental health and encourages GPs to consider hormonal and neurobiological factors in their assessment and management.

    Link & Resources:

    • Mothersafe NSW - https://www.seslhd.health.nsw.gov.au/royal-hospital-for-women/services-clinics/directory/mothersafe
    • TGA - Obstetric drug information services - https://www.tga.gov.au/resources/health-professional-information-and-resources/australian-categorisation-system-prescribing-medicines-pregnancy/prescribing-medicines-pregnancy-database/obstetric-drug-information-services
    • Perinatal Mental Health Guidelines - https://www.cope.org.au/uploads/images/Health-professionals/COPE_2023_Perinatal_Mental_Health_Practice_Guideline.pdf

    The Good GP Podcast is a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at www.talkinghealthtech.com/podcast/network

    If you have any questions or would like to contact The Good GP, send an email to thegoodgp@gmail.com. Visit www.thegoodgp.com.au for previous episodes and more information. You can also find us on our Instagram page: @thegoodgppodcast. Follow us for more updates!

    Show More Show Less
    24 mins